Edward Kaplan, M.D., is a medical oncologist and the director of gastrointestinal malignancies at City of Hope® Cancer Care North Shore, where he specializes in treating patients with colorectal, esophageal, gastric, biliary duct, hepatic and pancreatic cancer. With more than 30 years of experience in his field, Dr. Kaplan is committed to offering patients access to leading-edge treatment options, including precision medicine tools such as genomic testing and immunotherapy.
In his clinical work, Dr. Kaplan treats patients with a wide variety of cancer types and stages. In addition to gastrointestinal malignancies, he works with patients who are diagnosed with lung, breast, kidney, bladder, ovary, prostate and testicular cancer. He’s also passionate about improving cancer screening and risk management for people with inherited genetic mutations such as BRCA1 and BRCA2.
After earning his medical degree at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois, Dr. Kaplan completed a residency in internal medicine at Northwestern University in Chicago, followed by subspecialty training in hematology-oncology at the same institution, where he was named both a Galter Fellow and a Bill Veek Fellow.
A physician-scholar, Dr. Kaplan has written or co-authored dozens of peer-reviewed articles on topics ranging from immunotherapy to clinical trial protocols and the psychological impacts of lung cancer. He’s been an assistant professor at Rush University’s medical school in Chicago, where he also cofounded and was director of the Rush Cancer Institute’s Comprehensive Center for Gastrointestinal Malignancies.
